BioSig Technologies, Inc.
NASDAQ:BSGM
1.43 (USD) • At close December 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.018 | 0.286 | 0.441 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.057 | 0.199 | 0.55 | 0.054 | 0.012 | 0.012 | 0.01 | 0.01 | 0 | 0 | 0 | 0.007 |
| Gross Profit
| 0.018 | 0.229 | 0.242 | -0.55 | -0.054 | -0.012 | -0.012 | -0.01 | -0.01 | 0 | 0 | 0 | -0.007 |
| Gross Profit Ratio
| 1 | 0.801 | 0.549 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 5.092 | 5.821 | 5.602 | 18.136 | 9.739 | 4.369 | 4.756 | 2.655 | 1.239 | 0.548 | 0.992 | 0.889 | 0.583 |
| General & Administrative Expenses
| 23.077 | 21.38 | 27.853 | 40.954 | 24.811 | 12.881 | 8.138 | 8.499 | 10.795 | 7.304 | 5.229 | 1.291 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.072 | 0 |
| SG&A
| 23.077 | 21.38 | 27.853 | 40.954 | 24.811 | 12.881 | 8.138 | 8.499 | 10.795 | 7.304 | 5.229 | 1.363 | 0.484 |
| Other Expenses
| 0.361 | 0.293 | 0.198 | 0.094 | 0.054 | 0.012 | 0.012 | 0.01 | 0.01 | 0.016 | 0.017 | 0 | 0 |
| Operating Expenses
| 28.53 | 27.494 | 33.653 | 59.184 | 34.604 | 17.262 | 12.906 | 11.164 | 12.044 | 7.868 | 6.239 | 2.262 | 1.067 |
| Operating Income
| -28.512 | -27.265 | -33.411 | -59.184 | -34.604 | -17.262 | -12.906 | -11.164 | -12.044 | -7.868 | -6.239 | -2.262 | -1.073 |
| Operating Income Ratio
| -1,584 | -95.332 | -75.762 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.178 | 0.003 | 0.555 | 0.044 | 0.133 | 0.011 | 0.211 | -0.423 | 2.583 | -0.605 | -3.566 | -0.124 | -0.078 |
| Income Before Tax
| -28.69 | -27.262 | -32.856 | -59.14 | -34.471 | -17.251 | -12.696 | -11.587 | -9.461 | -8.473 | -9.805 | -2.386 | -1.151 |
| Income Before Tax Ratio
| -1,593.889 | -95.322 | -74.503 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.009 | -1.494 | -6.966 | -0.549 | 0.022 | -0.211 | 0.423 | -2.583 | 0.011 | 0.07 | 0.091 | 0 |
| Net Income
| -29.041 | -27.271 | -31.362 | -52.174 | -33.922 | -17.251 | -12.696 | -11.587 | -9.461 | -8.473 | -9.805 | -2.477 | -1.151 |
| Net Income Ratio
| -1,613.389 | -95.353 | -71.116 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -3.95 | -6.33 | -9.36 | -18.7 | -16.39 | -11.89 | -12.42 | -14.86 | -16.77 | -21.95 | -29.94 | -0.76 | -4.43 |
| EPS Diluted
| -3.95 | -6.33 | -9.36 | -18.7 | -16.39 | -11.89 | -12.42 | -14.86 | -16.77 | -21.95 | -29.94 | -0.76 | -4.43 |
| EBITDA
| -28.151 | -26.972 | -33.213 | -58.633 | -34.416 | -17.25 | -13.105 | -10.731 | -9.451 | -7.852 | -6.221 | -2.252 | -1.144 |
| EBITDA Ratio
| -1,563.944 | -94.308 | -76.567 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |